Article PDF
Rights and permissions
About this article
Cite this article
Technical and clinical assessment of fluorescence in situ hybridization: An ACMG/ASHG position statement. I. Technical considerations: Test and Technology Transfer Committee. Genet Med 2, 356–361 (2000). https://doi.org/10.1097/00125817-200011000-00011
Issue Date:
DOI: https://doi.org/10.1097/00125817-200011000-00011
This article is cited by
-
FISH is not Suitable as a Standalone Test for Detecting Fetal Chromosomal Abnormalities
Journal of Fetal Medicine (2015)
-
Rapid testing versus karyotyping in Down's syndrome screening: cost-effectiveness and detection of clinically significant chromosome abnormalities
European Journal of Human Genetics (2011)